ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)

Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.

Aki Furusawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.